COMMUNIQUÉS West-GlobeNewswire
-
Assertio to Present at the Citizens JMP Life Sciences Conference in New York City
10/05/2024 - 21:12 -
Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam
10/05/2024 - 22:02 -
Longeveron Announces Board of Directors Planned Transitions
10/05/2024 - 22:05 -
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/05/2024 - 22:05 -
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/05/2024 - 22:05 -
Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
10/05/2024 - 22:05 -
Atrion Reports First Quarter 2024 Results
10/05/2024 - 22:10 -
Entera Bio Reports Q1 2024 Financial Results and Provides Business Updates
10/05/2024 - 22:10 -
Evaxion Receives Nasdaq Notification
10/05/2024 - 23:00 -
Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/05/2024 - 23:38 -
Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives
10/05/2024 - 23:40 -
Merus annonce ses résultats financiers pour le premier trimestre 2024 et fait le point sur ses activités
10/05/2024 - 18:36 -
AFB Releases Phase 2 Study of Barriers to Digital Inclusion
10/05/2024 - 18:39 -
Nika Pharmaceuticals, Inc. (Nika) Acquires a Two Million USD Production Building
10/05/2024 - 18:55 -
Nika Pharmaceuticals, Inc. (NIKA) Acquires a Two Million USD Production Building
10/05/2024 - 19:41 -
Le King Faisal Specialist Hospital & Research Centre chef de file de la transformation du secteur de la santé en Arabie saoudite
10/05/2024 - 20:19 -
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
10/05/2024 - 20:43 -
Optinose Announces Reporting Date for First Quarter 2024 Financial Results
10/05/2024 - 20:56 -
Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024
10/05/2024 - 15:00
Pages